◆ 会议时间：2022年11月10日至13日
◆ 会议地点：匈牙利 布达佩斯

◆ 会议简介：

2022年第14届欧洲泌尿系统肿瘤多学科大会(EMUC2022)将于2022年11月10日至13日在匈牙利布达佩斯举行，EMUC是欧洲最大的泌尿系统肿瘤学会议，由欧洲肿瘤内科学会（ESMO）、欧洲放射治疗与肿瘤学会（ESTRO）和欧洲泌尿外科协会（EAU）/欧洲泌尿外科学院（ESU）合作举办。为期四天的会议，来自欧洲以及欧洲以外其他国家众多的肿瘤学家、放射科医师、病理学家和泌尿科医师将分享他们的知识与经验，并对泌尿生殖系统肿瘤(GU)的最新研究进展进行认真评估和提出见解-领域国际医学会议网。EMUC至今已成举办十二届，现已建立了作为专业和科学交流领先平台宣的声誉，它不仅对有争议的问题进行批判性的审视，而且还对临床实践中的实际见解进行审视评估。无论是关于创新治疗的重要辩论，标准治疗的局限性还是新研究成果的影响，EMUC都是一次前沿的协作会议，旨在确定最佳疗法并解决临床实践中的空白。未经许可禁止复制摘录转载本站任何内容-国际医学会议网(lingyuint.com)

EMUC21科学计划将包括预防、诊断和管理泌尿生殖系统（GU）癌症方面的当前相关进展，其范围将包括世界卫生组织对膀胱癌的最新分类、前列腺癌的现代成像、非肌层浸润性膀胱癌的综合系统治疗、主要试验的最新进展、该领域的最新分子发展等。在EMUC21上，还将解决当前存在的争议和挑战，例如优化利用诊断工具（包括分子标记物）以实现个性化治疗方法，为患者实现最大利益。

The 14th European Multidisciplinary Congress on Urological Cancers (EMUC22)
Date: 10-13 November, 2022
Venue: Budapest Congress Center, Budapest, Hungary

摘要征集：

点此提交摘要>>>Submit Abstract>>>

Rules
Download the abstract submission rules here

Topics
Prostate Cancer, Localised – Basic Research & Trials
Prostate Cancer, Localised – Diagnosis
Prostate Cancer, Localised – Diagnosis, Pathology & Biopsies
Prostate Cancer, Localised – Treatment
Prostate Cancer, Localised – Follow up
Prostate Cancer, Localised – Follow up, Clinical / Prognosis
Prostate Cancer, Localised – Follow up, Quality of life / Patient reported outcomes
Prostate Cancer, Locally advanced – Basic Research & Trials
Prostate Cancer, Locally advanced – Diagnosis
Prostate Cancer, Locally advanced – Diagnosis, Pathology & Biopsies
Prostate Cancer, Locally advanced – Treatment
Prostate Cancer, Locally advanced – Follow up
Prostate Cancer, Locally advanced – Follow up, Clinical / Prognosis
Prostate Cancer, Locally advanced – Follow up, Quality of life / Patient reported outcomes
Prostate Cancer, Metastatic – Basic Research & Trials
Prostate Cancer, Metastatic – Diagnosis
Prostate Cancer, Metastatic – Diagnosis, Pathology & Biopsies
Prostate Cancer, Metastatic – Treatment
Prostate Cancer, Metastatic – Follow up
Prostate Cancer, Metastatic – Follow up, Clinical / Prognosis
Prostate Cancer, Metastatic – Follow up, Quality of life / Patient reported outcomes
Renal Tumour – Basic Research & Trials
Renal Tumour – Diagnosis
Renal Tumour – Treatment
Renal Tumour – Follow up, Clinical / Prognosis
Renal Tumour – Follow up
Renal Tumour – Follow up, Quality of life / Patient reported outcomes
Renal Tumour – Diagnosis, Pathology & Biopsies
Urothelial Cancer – Basic Research & Trials
Urothelial Cancer – Diagnosis
Urothelial Cancer – Diagnosis, Pathology & Biopsies
Urothelial Cancer – Treatment
Urothelial Cancer – Follow up
Urothelial Cancer – Follow up, Clinical / Prognosis
Urothelial Cancer – Follow up, Quality of life / Patient reported outcomes
Testicular Cancer – Diagnosis
Testicular Cancer – Treatment
Testicular Cancer – Follow up, Clinical / Prognosis
Testicular Cancer – Diagnosis, Pathology & Biopsies
Penile Cancer – Basic Research & Trials
Penile Cancer – Diagnosis
Penile Cancer – Diagnosis, Pathology & Biopsies
Penile Cancer – Treatment
Penile Cancer – Follow up
Penile Cancer – Follow up, Clinical / Prognosis
Penile Cancer – Follow up, Quality of life / Patient reported outcomes
Non-Disease specific

Publication

The accepted abstracts of EMUC22 are going to be published online in the EMUC resource centre, in the EMUC/ESUI app and as an online supplement by Elsevier on European Urology Open Science. If you do not want your case report(s) or video(s) published online please send an e-mail to emuc@congressconsultants.com.

Please note: Copyright of the abstract(s) is assigned to the EMUC office and any conflicts with any other scientific association will be the sole responsibility of the author(s).

Dear friends and colleagues,

Our commitment to provide a stellar, multidisciplinary approach when offering the best uro-oncological care to our patients, remains unchanged. The scientific programme of the upcoming 14th European Multidisciplinary Congress on Urological Cancers (EMUC22) will comprise of contemporary and relevant developments in the prevention, diagnosis and management of genito-urinary (GU) cancers.

Join us from 10 to 13 November 2022 in the historic Hungarian capital Budapest for a myriad of vital updates on major trials, emerging technologies, pioneering techniques, and strategies. These will be presented in dedicated sessions and hands-on trainings, interspersed with lively and insightful deliberations.

We have entered a new era wherein metastatic GU cancers can be associated with achievable cure and long-term survival without disease progression. This is thanks to the close involvement of diverse disciplines and collaboration of the European Society for Medical Oncology (ESMO), the European SocieTy Radiation Oncology (ESTRO) and the European Association of Urology (EAU).

EMUC22 will take place in conjunction with the 10th Meeting on the EAU Section on Urological Imaging (ESUI22), European School of Urology (ESU) courses, EMUC Symposium on Genitourinary Pathology and Molecular Diagnostics (ESUP) and the Young Academic Urologists Meeting (YAU).

We look forward to welcoming you in Budapest!

注册费：

◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。